Validation of Myocardial Perfusion Imaging

PHASE4CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Coronary Artery Disease
Interventions
PROCEDURE

coronary angiography

A 6 French arterial sheath was introduced into the radial artery. After administration of 5000 U heparin, the guiding catheter was advanced into the coronary ostium. Intracoronary nitroglycerin 0.2 mg was administered, and reference images were made. Significant CAD was defined as presentation of a stenosis ≥70 % in the three-epicardial vessels and ≥ 50 % in left main coronary disease. If necessary (at the discretion of the practitioner) the pressure wire was advanced across the stenosis, and Fractional flow reserve (FFR) was measured.

Trial Locations (1)

Unknown

University Hospital, Grenoble

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT01785589 - Validation of Myocardial Perfusion Imaging | Biotech Hunter | Biotech Hunter